Altamira Therapeutics Ltd. (CYTO) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
At the recent Annual General Meeting, Altamira Therapeutics Ltd. shareholders elected four Board of Directors members and re-elected their auditors for the 2024 financial year. Shareholders also approved the executive compensation, authorized a reduction in share premium account to increase the contributed surplus, and sanctioned an increase in authorized share capital to create additional common shares.
For further insights into CYTO stock, check out TipRanks’ Stock Analysis page.